370 likes | 673 Views
Sex, Stress & Heart Disease. Cardiology Update Mazankowski Alberta Heart Institute / University of Alberta May 3, 2014. Dr. David E. Johnstone, MD, FRCPC, FACC Zone Clinical Department Head Cardiac Sciences, Edmonton. Sex, Stress & Heart Disease. Learning Objectives
E N D
Sex, Stress & Heart Disease Cardiology Update Mazankowski Alberta Heart Institute / University of Alberta May 3, 2014 Dr. David E. Johnstone, MD, FRCPC, FACC Zone Clinical Department Head Cardiac Sciences, Edmonton
Sex, Stress & Heart Disease Learning Objectives • How stressful is sex in cardiac patients? • When can patients resume sexual activities? • The answer to the question “can I take Viagra?” • Who should not have sex? • Why do we avoid this topic?
Cardiac Workshop: Warm-up Questions • Who we are / what do we do? • Discussed sex with a CV patient? • Male / Female • Any previous bad experiences? • Drugs for erectile dysfunction • Complications • Topic covered previously
Cardiac Workshop: Guidelines • Interactive • Useful Information • Advice regarding specific patients • Broaden discussion if this topic covered
Quality Care 63 year old man presents with chest pain and an inferior STEMI. Urgent cardiac cath revealed an occluded RCA and subcritical LAD & Cx disease. Successful PCI with drug eluting stent • ASA / Plavix / Lipitor • FU • Family Physician • Rehabilitation • Advice • Work, driving, Etc.
How Risky is Sex in the CV Patient; Angina • Infrequent (<5%) • Sedentary patients / severe CAD • Other names • Coital angina • Angina d’amour
How Risky is Sex; Myocardial Infarction • Infrequent (<1%) • Sedentary patients (3 fold) • Post MI / Unknown CAD, equal risk • 10 vs 20 chances in 1,000,000 per hour
How Risky is Sex; Sudden Cardiac Death • Rare (0.6%) • Majority male (85%) • 75% extramarital • Younger partner • Food / Alcohol
CCS Functional Class of Angina • Ordinary Activity shovel snow sports • Slight Limitation of Ordinary Activity > 2 blocks > 2 flights - sex • Marked Limitation housework < 2 blocks 1 flight 4. Can’t Do Anything < 2 METS
Sex; General Recommendations • Exercise > 3 – 5 METS • Rehab – useful • Unstable symptoms (angina / CHF) • No sex
62 year old male with stable angina reports new episodes of angina. What should you do?
New Angina During Sex • Give him Viagra • Details needed • Exercise test • Holter / Loop recorder • Send to ER
Sex Following MI; Historical Perspective • 6 – 8 weeks (80’s) • 3 – 4 weeks (2005) • 1 week (2012)
Sex Post Cardiac Procedures PCI / Stents • Complete vs incomplete revascularization • Femoral vs Radial CV Surgery • 6 – 8 weeks • Sternotomyvs minimally invasive • Emotional time / Rehab helps
Heart Failure & Sex • Sexual dysfunction common (85%) • Cessation of sexual activity (25%) • Correlates with functional capacity • Quality of life vs survival
Heart Failure & Sex; Recommendations • Reasonable for FC 1 & 2 patients • Not advised for decompensated or FC 3/4 patients • LV function (EF) not helpful
Valvular Heart Disease & Sex • No science • Function class important • Stress test helpful
Valvular Disease; Sex & Women • Pregnancy may have added dangers • Mechanical valves, anticoagulation and risk to fetus • Inadequate anticoagulation and risk to mom
Electrical Heart Disease, Devices & Sex • Atrial fib / flutter • Rate control • Pacemaker / ICDs • Healing phase • ICDs • Heart rate threshold • Fear of discharge
36 year old male, professional with coronary spasm • Asymptomatic • EF 30-35% • Bisoprolol, Perindopril • Several shocks during sex • What caused the shocks? • Was the female partner at risk?
Cardiomyopathies & Sex • Hypertrophic CM • Risk of sudden death • Young > Older • Congestive CM • Post-partum CM pregnancy risk • Function class key
Cardiovascular Drugs & Sex; Beta Blockers True or False • B-blockers frequently cause erectile dysfunction • B-blockers cause impotence • Nocebo effect is a major contributor
Cardiovascular Drug & Sex; Beta Blockers • Sexual dysfunction 5 / 1,000 • Impotence 3 / 1,000 (6 studies, 15,000 patients) • What patients / MDs think important (Nocebo)
Cardiovascular Drugs & Sex; Some Facts • Thiazides may contribute to vaginal lubrication issues • Spironolactone causes decrease libido / breasts • ED on thiazide, switch to loop diuretic
CV Drugs & Sexual Function; Recommendation • CV drugs that improve symptoms and survival should not be withheld • Dig deeper to exclude other causes • Consider ED therapies in stable patients
Drugs for Sexual Dysfunction in the CV Patient • Phosphodiesterase – 5 Inhibitor (PDE5) cause vasodilation • Are effective • Mild reduction in systolic BP • Not associated with MI / cardiac events • Viagra most studied
Advice from the audience about experiences with various PDE-5 Inhibitors in CV patients • Any differences? • Any preferences? • Any bad experiences?
Vardenafil (Levitra) • Avoid with Class 1 (quinidine) and Class 3 (Amiodarone, Sotalol) • Pharmacokinetics of Levitra NOT influenced by alcohol • Pharmacokinetics of alcohol NOT influenced by Levitra
Organic Nitrates & PDE-5 Inhibitors in CV Patients • PDE 5 inhibitors should not be used in patients on NTG • Nitrates should not be administered to patients within 24 hours Viagra and 48 hours for Cialis
48 year old male with prior MI • Successful stenting. Asymptomatic • Travels extensively. EF – 40% • Approved / educated about Viagra and Nitrates • Presyncope and mad as hell ? Why
Sildenafil in Heart Failure Patients • Safe in controlled HF despite severe LV dysfunction • Similar BP / pulse changes to other patients Webster LJ, Michilakis ED et al Arch Intern Med 2004; 164;5 14-520
Erectile Dysfunction & Cardiovascular Risk • Australian Study (100,000 men) • Severe dysfunction % • Age 45 – 54 2 • Age 55 – 64 7 • Age 65 – 74 20 • Age 75 – 84 50 • 85 & Over 75
Erectile Dysfunction & Cardiovascular Risk • Modest increased risk (1.6) in severe ED • Risk marker not risk factor Banks E et al. Pub Med, Jan 29, 2013
PDE-5 Inhibitors & Specific Subgroups • Safety unknown in severe AS • Vardenafil carries a warning regarding prolonged QT
Psychological Issues to Deal With • Do we discuss? • Who should discuss?